214 related articles for article (PubMed ID: 20457602)
1. The role of SnoN in transforming growth factor beta1-induced expression of metalloprotease-disintegrin ADAM12.
Solomon E; Li H; Duhachek Muggy S; Syta E; Zolkiewska A
J Biol Chem; 2010 Jul; 285(29):21969-77. PubMed ID: 20457602
[TBL] [Abstract][Full Text] [Related]
2. Requirement for the SnoN oncoprotein in transforming growth factor beta-induced oncogenic transformation of fibroblast cells.
Zhu Q; Pearson-White S; Luo K
Mol Cell Biol; 2005 Dec; 25(24):10731-44. PubMed ID: 16314499
[TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic protein-7 inhibits proximal tubular epithelial cell Smad3 signaling via increased SnoN expression.
Luo DD; Phillips A; Fraser D
Am J Pathol; 2010 Mar; 176(3):1139-47. PubMed ID: 20093492
[TBL] [Abstract][Full Text] [Related]
4. Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation.
Levy L; Howell M; Das D; Harkin S; Episkopou V; Hill CS
Mol Cell Biol; 2007 Sep; 27(17):6068-83. PubMed ID: 17591695
[TBL] [Abstract][Full Text] [Related]
5. Participation of an abnormality in the transforming growth factor-beta signaling pathway in resistance of malignant glioma cells to growth inhibition induced by that factor.
Zhang L; Sato E; Amagasaki K; Nakao A; Naganuma H
J Neurosurg; 2006 Jul; 105(1):119-28. PubMed ID: 16871886
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the constitutive complex formation of c-Ski/SnoN with Smads in the impaired negative feedback regulation of transforming growth factor beta signaling in scleroderma fibroblasts.
Jinnin M; Ihn H; Mimura Y; Asano Y; Tamaki K
Arthritis Rheum; 2007 May; 56(5):1694-705. PubMed ID: 17469184
[TBL] [Abstract][Full Text] [Related]
7. Smad2 and Smad3 play antagonistic roles in high glucose-induced renal tubular fibrosis via the regulation of SnoN.
Wang Y; Zhang X; Mao Y; Liang L; Liu L; Peng W; Liu H; Xiao Y; Zhang Y; Zhang F; Shi M; Liu L; Guo B
Exp Mol Pathol; 2020 Apr; 113():104375. PubMed ID: 31917288
[TBL] [Abstract][Full Text] [Related]
8. Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN.
Stroschein SL; Bonni S; Wrana JL; Luo K
Genes Dev; 2001 Nov; 15(21):2822-36. PubMed ID: 11691834
[TBL] [Abstract][Full Text] [Related]
9. SnoN suppresses maturation of chondrocytes by mediating signal cross-talk between transforming growth factor-β and bone morphogenetic protein pathways.
Kawamura I; Maeda S; Imamura K; Setoguchi T; Yokouchi M; Ishidou Y; Komiya S
J Biol Chem; 2012 Aug; 287(34):29101-13. PubMed ID: 22767605
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta1-mediated activation of NF-kappaB contributes to enhanced ADAM-12 expression in mammary carcinoma cells.
Ray A; Dhar S; Ray BK
Mol Cancer Res; 2010 Sep; 8(9):1261-70. PubMed ID: 20688878
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of SnoN expression in obstructive nephropathy is mediated by an enhanced ubiquitin-dependent degradation.
Tan R; Zhang J; Tan X; Zhang X; Yang J; Liu Y
J Am Soc Nephrol; 2006 Oct; 17(10):2781-91. PubMed ID: 16959829
[TBL] [Abstract][Full Text] [Related]
12. The downregulation of SnoN expression in human renal proximal tubule epithelial cells under high-glucose conditions is mediated by an increase in Smurf2 expression through TGF-β1 signaling.
Li X; Diao Z; Ding J; Liu R; Wang L; Huang W; Liu W
Int J Mol Med; 2016 Feb; 37(2):415-22. PubMed ID: 26743567
[TBL] [Abstract][Full Text] [Related]
13. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
He J; Tegen SB; Krawitz AR; Martin GS; Luo K
J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
[TBL] [Abstract][Full Text] [Related]
14. Proteomic identification of ADAM12 as a regulator for TGF-β1-induced differentiation of human mesenchymal stem cells to smooth muscle cells.
Kim YM; Kim J; Heo SC; Shin SH; Do EK; Suh DS; Kim KH; Yoon MS; Lee TG; Kim JH
PLoS One; 2012; 7(7):e40820. PubMed ID: 22808268
[TBL] [Abstract][Full Text] [Related]
15. The SMAD2/3 corepressor SNON maintains pluripotency through selective repression of mesendodermal genes in human ES cells.
Tsuneyoshi N; Tan EK; Sadasivam A; Poobalan Y; Sumi T; Nakatsuji N; Suemori H; Dunn NR
Genes Dev; 2012 Nov; 26(22):2471-6. PubMed ID: 23154981
[TBL] [Abstract][Full Text] [Related]
16. The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbeta1 responses in human proximal-tubule epithelial cells.
Phanish MK; Wahab NA; Colville-Nash P; Hendry BM; Dockrell ME
Biochem J; 2006 Jan; 393(Pt 2):601-7. PubMed ID: 16253118
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the serine/threonine p70S6 kinase in TGF-beta1-induced ADAM12 expression in cultured human hepatic stellate cells.
Le Pabic H; L'Helgoualc'h A; Coutant A; Wewer UM; Baffet G; Clément B; Théret N
J Hepatol; 2005 Dec; 43(6):1038-44. PubMed ID: 16139919
[TBL] [Abstract][Full Text] [Related]
18. Metalloprotease-disintegrin ADAM12 expression is regulated by Notch signaling via microRNA-29.
Li H; Solomon E; Duhachek Muggy S; Sun D; Zolkiewska A
J Biol Chem; 2011 Jun; 286(24):21500-10. PubMed ID: 21518768
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis for the cell type specific induction of SnoN expression by hepatocyte growth factor.
Tan R; Zhang X; Yang J; Li Y; Liu Y
J Am Soc Nephrol; 2007 Aug; 18(8):2340-9. PubMed ID: 17625116
[TBL] [Abstract][Full Text] [Related]
20. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells.
Edmiston JS; Yeudall WA; Chung TD; Lebman DA
Cancer Res; 2005 Jun; 65(11):4782-8. PubMed ID: 15930298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
